Medipharm Labs Corp (LABS)

Currency in CAD
0.08
0.00(0.00%)
Closed·
LABS Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
LABS is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.080.08
52 wk Range
0.060.12
Key Statistics
Bid/Ask
0.07 / 0.08
Prev. Close
0.08
Open
0.08
Day's Range
0.08-0.08
52 wk Range
0.06-0.12
Volume
177.18K
Average Volume (3m)
223.53K
1-Year Change
23.08%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
LABS Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
0.00
Downside
-100.00%
Members' Sentiments
Bearish
Bullish
ProTips
High shareholder yield

Medipharm Labs Corp News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Sell
Moving Averages
Sell

Medipharm Labs Corp Company Profile

MediPharm Labs Corp. operates as a pharmaceutical company that produces and sells purified, pharmaceutical-quality cannabis extracts, concentrates, active pharmaceutical ingredients, and advanced derivative products in Canada, Australia, Germany, and internationally. The company formulates, develops, processes, packages, and distributes cannabis active ingredients and advanced cannabinoid-based products. It also provides good manufacturing practice flower sourcing, packaging, and distribution services, as well as dried flower and pre-roll cannabis products. In addition, the company offers cannabis related medical information and services; and medical cannabis clinic services. MediPharm Labs Corp. was founded in 2015 and is based in Barrie, Canada.

Employees
161
Market
Canada

Medipharm Labs Corp Earnings Call Summary for Q2/2025

  • MediPharm Labs reported 14% revenue growth to $11.8M in Q2 2025, driven by 50% surge in international medical cannabis sales
  • Despite revenue growth, adjusted EBITDA remained negative at -$600,000; stock price fell 16.67% post-earnings to $0.07
  • Company maintains strong balance sheet with $10.4M cash and virtually no debt; gross profit margin at 71.03%
  • Management focuses on international expansion and product innovation to achieve future profitability and positive cash flow
  • No specific guidance provided for upcoming quarters; CEO expresses confidence in company's strategic direction
Last Updated: 14/08/2025, 15:52
Read Full Transcript

Compare LABS to Peers and Sector

Metrics to compare
LABS
Peers
Sector
Relationship
P/E Ratio
−3.9x−0.1x−0.5x
PEG Ratio
−0.100.000.00
Price/Book
0.8x1.0x2.6x
Price / LTM Sales
0.8x0.8x3.3x
Upside (Analyst Target)
-18.1%38.7%
Fair Value Upside
Unlock24.8%5.0%Unlock

Analyst Ratings

0 Buy
1 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 0.00

Earnings

Latest Release
Aug 14, 2025
EPS / Forecast
-0.01 / -0.0031
Revenue / Forecast
11.81M / 11.01M
EPS Revisions
Last 90 days

LABS Income Statement

People Also Watch

18.27
NFI
-0.49%
4.770
WELL
-0.83%
1.86
BITF
+4.49%
43.16
CNQ
+2.37%
85.13
BNS
+0.18%

FAQ

What Stock Exchange Does Medipharm Trade On?

Medipharm is listed and trades on the Toronto Stock Exchange stock exchange.

What Is the Stock Symbol for Medipharm?

The stock symbol for Medipharm is "LABS."

What Is the Medipharm Market Cap?

As of today, Medipharm market cap is 33.66M.

What Is Medipharm's Earnings Per Share (TTM)?

The Medipharm EPS (TTM) is -0.02.

When Is the Next Medipharm Earnings Date?

Medipharm will release its next earnings report on 16 Nov 2025.

From a Technical Analysis Perspective, Is LABS a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Medipharm Stock Split?

Medipharm has split 1 times.

How Many Employees Does Medipharm Have?

Medipharm has 161 employees.

What is the current trading status of Medipharm (LABS)?

As of 27 Aug 2025, Medipharm (LABS) is trading at a price of 0.08, with a previous close of 0.08. The stock has fluctuated within a day range of 0.08 to 0.08, while its 52-week range spans from 0.06 to 0.12.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.